Nineteen patients (12 men) mean age, 63.4 years (range, 32 to 78), with stable chronic
airflow limitation, mean FEV 1, 0.55 L (range, 0.3 to 1.05 L), completed an eight-week …

Nine patients with severe chronic airway obstruction secondary to chronic bronchitis and
emphysema all preferred nebulised salbutamol solution to placebo in a double-blind …

Two studies are presented, with the aim of establishing the dose potency ratio for salbutamol
given via Turbuhaler and via a pressurized metered-dose inhaler (pMDI). Both studies were …

Dose-response relationships for salbutamol were studied in eight patients suffering from
chronic airflow obstruction with no asthmatic features. Each inhaled, double blind, in …

The most common way of treating exacerbations of asthma and chronic airflow limitation
(CAL) in hospital emergency rooms and on the wards is by means of bronchodilator …

Inhalers and nebulisers are devices used for delivering aerosolised drugs in subjects with
Chronic Airflow Obstruction (CAO). This multicentre, cross-sectional observational study was …

BACKGROUND: The aim of this study was to determine whether significant differences exist
in lung bioavailability between generic (Salamol, Salbulin) and innovator (Ventolin) …

BACKGROUND: Salbutamol, the most widely used short-acting β2-agonist, consists of a
racemic mixture of equal amounts of two enantiomers,(R)-salbutamol and (S)-salbutamol …

In a double-blind cross-over study 20 patients with reversible airways obstruction were
treated either with conventional 4 mg tablets of salbutamol aid, or 8 mg controlled release …

We conducted a trial of inhaled salbutamol and orally administered theophylline in patients
whose acute response to inhaled salbutamol was less than 25% of their baseline FEV1 …